Predicting Rheumatoid Arthritis Treatment Success New Biomarker Breakthrough Key Takeaways Rheumatoid arthritis is a chronic systemic autoimmune disease affecting approximately 1 percent of the global population. Despite major advances in biologic and targeted synthetic disease modifying antirheumatic drugs, treatment success remains highly variable. Approximately
Tag: DMARDs
Are We Overtreating Early Rheumatoid Arthritis in the Biologic Era?
Are We Overtreating Early Rheumatoid Arthritis in the Biologic Era Abstract The introduction of biologic disease modifying antirheumatic drugs has fundamentally reshaped the management of rheumatoid arthritis over the past two decades. These agents, in combination with conventional synthetic therapies and treat to target strategies, have significantly
